Loading…
ETON
Eton Pharmaceuticals, Inc.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP 29772L108
$50.31-1.99%Price as of Oct 17, 12:04 UTC · updated once a day, after the close
At a glance
Eton Pharmaceuticals, Inc. (ETON) is listed on NASDAQ and classified in Drug Manufacturers - Specialty & Generic, part of the Healthcare sector. It is headquartered in Deer Park, United States and has 44 employees. The company is worth $1.44B and trades at 125.8x its earnings of the last twelve months; the median for its sector is 24.3x. Revenue was $79.95M in fiscal 2025, up 104.9% from the year before. It reported a net loss of $4.6M. The share price is 24.2% below its 52-week high of $66.37. 4 of the 38 superinvestors we track held it at the end of Q2 2026. The largest position belongs to Two Sigma (Two Sigma Investments), at $4.21M. In that quarter, 1 of them opened or added to the position and 2 reduced it. Over the last 30 days, company insiders sold $229.41K of its stock on the open market and bought none.
Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.
Key metrics
- Market cap
- $1.44B
- P/E
- 125.8x
- Forward P/E
- 19.7x
- P/B
- 30.5x
- Dividend yield
- 0.00%
- Payout
- —
- EPS
- $0.40
- ROE
- 35.97%
- Profit margin
- 12.02%
- Revenue growth
- +98.60%
- Beta
- 0.90
- 52-week high
- $66.37
- 52-week low
- $14.27
History
Year by year, from the annual reports; dividends from the payments themselves.
Bars are year-end balances; lines are what happened during the year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▲ +1190.0% over 5Y.
today you would have $8,734.37▲ +773.4%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 8 closed years, each at that year’s closing price and reported numbers.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Year-end price | $16.91 | $13.32 | $4.38 | $2.82 | $4.29 | $8.13 | $7.20 | $6.12 | |
| P/S | 5.8x | 5.8x | 9.2x | 3.6x | 3.4x | 4.8x | 5088.0x | 134.3x | — |
| P/B | 9.3x | 17.6x | 14.6x | 7.3x | 5.5x | 6.0x | 11.3x |
Fair price, seven ways
Seven formulas applied to the reported numbers, each with its assumption next to the result. None of them predicts a price.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
$9.71
Median P/E of 24.3 among peers in the sector.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
$5.95
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Dividends
—
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ANABAnaptysbio Inc | $48.10 | — | 135.1x | 0.00% | — | $1.44B |
| AAPGAscentage Pharma Group International | $15.37 | — | 17.2x | 0.00% | -236.63% | $1.44B |
| INBXInhibrx Biosciences, Inc. | $97.10 | — | — | 0.00% | -1773.60% | $1.43B |
| PCRXPacira BioSciences, Inc. | $36.34 |
About the company
- 44
- Deer Park, United States